SMPD3 and myelodysplastic syndrome: Our previous work has demonstrated that there were six DEGs identified as potential biomarkers for diagnosis of MDS, including ABAT, DAPP1, FADD, LRRFIP1, PLBD1, and SMPD3 (11).